Phase II Study of Yttrium-90 Ibritumomab Tiuxetan Plus High-Dose BCNU, Etoposide, Cytarabine, and Melphalan for Non-Hodgkin Lymphoma: The Role of Histology-Reference-Cited by-同舟云学术

Phase II Study of Yttrium-90 Ibritumomab Tiuxetan Plus High-Dose BCNU, Etoposide, Cytarabine, and Melphalan for Non-Hodgkin Lymphoma: The Role of Histology

Published:2017-06 Issue:6 Volume:23 Page:922-929
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Krishnan Amrita Y.,Palmer Joycelynne,Nademanee Auayporn P.,Chen Robert,Popplewell Leslie L.,Tsai Ni-Chun,Sanchez James F.,Simpson Jennifer,Spielberger Ricardo,Yamauchi Dave,Forman Stephen J.

Funder

National Cancer Institute

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference46 articles.

1. Total body irradiation—report on a meeting organized by the BIR Oncology Committee, held at The Royal Institute of British Architects, London, 28 November 1996;Gilson;Br J Radiol,1997

2. Matched-cohort analysis of autologous hematopoietic cell transplantation with radioimmunotherapy versus total body irradiation-based conditioning for poor-risk diffuse large cell lymphoma;Krishnan;Biol Blood Marrow Transplant,2012

3. High-dose therapy in diffuse large cell lymphoma: results and prognostic factors in 452 patients from the GEL-TAMO Spanish Cooperative Group;Caballero;Ann Oncol,2003

4. Radioimmunotherapy of non-Hodgkin lymphomas;Cheson;Blood,2003

5. Randomized controlled trial of Yttrium-90—labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma;Witzig;J Clin Oncol,2002

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Navigating the landscape of theranostics in nuclear medicine: current practice and future prospects;Zeitschrift für Naturforschung C;2024-05-29

2. Therapeutic Monoclonal Antibodies for Non-Hodgkin Lymphoma: A Literature Review;Current Cancer Therapy Reviews;2024-01

3. Anti-CD25 radioimmunotherapy with BEAM autologous hematopoietic cell transplantation conditioning in Hodgkin lymphoma;Blood Advances;2021-12-08

4. Theranostics of Hematologic Disorders;Nuclear Medicine and Immunology;2021-11-25

5. Radioimmunotherapy in Oncology: Overview of the Last Decade Clinical Trials;Cancers;2021-11-07